Algernon Pharmaceuticals completed its clinical trial agreement with Westchester Research Center at Westchester General Hospital in Miami, Florida, for its multinational Phase IIb/III trial of NP-120 (ifenprodil) for COVID-19. The trial is expected to start after July 20.
Rakovina has been selected to join a three year US$975,000 (CDN1,297,000) research program funded by the St. Baldrick’s Foundation..
This initiative will provide the necessary investments to advance apabetalone for potential treatment of Covid in the Arab-African Economy
Apabetalone is the only drug of its class with a well-established safety record in human clinical trials...